62
Participants
Start Date
November 30, 2014
Primary Completion Date
December 31, 2016
Study Completion Date
July 31, 2018
Sunitinib
Identify prognosis and predictive biomarkers of response to sunitinib and pazopanib as first line therapy in avanced or metastatic renal cell carcinoma.
Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela
Hospital Universiario de León, León
Hospital Gregorio Marañón, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hospital Clínico (Madrid), Madrid
Hospital 12 de Octubre, Madrid
Hospital Universitario Carlos Haya, Málaga
Hospital Universitario central de Asturias, Oviedo
Hospital Marqués de Valdecilla, Santander
Hospital Clínico Lozano Blesa, Zaragoza
Hospital Universitarios de Burgos, Burgos
Hospital Universitario La Paz, Madrid
Spanish Oncology Genito-Urinary Group
OTHER